Cargando…
Metronomic Dosing for Pancreatic Cancer Combination Therapy Treatment Association With Reduced Neutropenia
Metronomic dosing for pancreatic cancer combination therapy treatment association with reduced neutropenia. METHODS: This research aims to evaluate the use of combination therapy for shrinking tumor size in patients with metastatic pancreatic cancer using gemzar/paclitaxel combination therapy for tr...
Autores principales: | Gill, Sharoon, Killian, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906525/ http://dx.doi.org/10.1200/GO.22.22000 |
Ejemplares similares
-
Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC
por: Skavatsou, Eleni, et al.
Publicado: (2021) -
Reducing Geographic Barriers for Breast Cancer Diagnosis
por: Adaniya, Emily, et al.
Publicado: (2022) -
Patient Socioeconomic and Cultural Factors Associated With Fidelity to Guideline-Concordant Breast Cancer Therapy Delivery in Botswana
por: Mokokwe, Lebogang T., et al.
Publicado: (2022) -
Presenting Symptoms and Stage at Diagnosis Among Women Diagnosed With Breast Cancer Through a Combined Breast Cancer and Cervical Cancer Screening Program in Rwanda
por: Pace, Lydia, et al.
Publicado: (2022) -
Effective Innovative Models of Health Care Delivery in the Era of the COVID-19 Pandemic to Reduce Disparities in Cancer Care and for Cancer Control in Low-Middle Income Countries—South African Experience of the Cancer ECHO Model
por: Osei-Fofie, Daniel
Publicado: (2022)